This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (53)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Use of New Tests

P. A. OWREN, M.D.

Arch Intern Med. 1963;111(2):248-258.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The goal of anticoagulant therapy is to prevent thrombosis, but to preserve hemostasis. We would like to give the highest intensity of therapy possible without undue risk of hemorrhage. Therefore, if we could establish criteria for the critical level of hypoagulability below which hemorrhagic tendency will be too high to be accepted, this would give us a sound basis for evaluating different methods and for selecting techniques which are sensitive in signaling the crossing of the critical border into the area of high hemorrhagic risk.

Hemostasis proceeds through 3 main stages (Fig. 1). The initial reaction of platelet adhesion and reversible aggregation is independent of coagulation.

The second reaction, however, of irreversible aggregation and viscous metamorphosis, which produces impermeability of the platelet plug and arrest of bleeding, requires thrombin. We have found that thrombin for this process is provided by clotting factors which are adsorbed on the platelet surface and . . . [Full Text PDF of this Article]

Author Affiliations
OSLO, NORWAY

University Hospital.

Footnotes
Received for publication Sept. 4, 1962; accepted Oct. 5.

Read before the Joint Meeting on Anticoagulant and Thrombolytic Therapy with the American Heart Association at the 111th Annual Meeting of the American Medical Association, Chicago, June 26, 1962.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?